Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis

Arthritis Care and Research

Volumn 53, Issue 5, 2005, Pages 732-739

  Blalock, Susan J ^a   Norton, Linda L ^b   Patel, Rajul A ^b   Dooley, Mary Anne ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Glucocorticoids; Health behavior; Osteoporosis; Patient Education

Indexed keywords

CALCIUM; ETANERCEPT; GLUCOCORTICOID; GOLD; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE; VITAMIN D;

ADULT; AGED; ARTHRITIS; ARTICLE; BONE DENSITY; BONE MASS; CALCIUM INTAKE; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; FEMALE; HEALTH BEHAVIOR; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PATIENT COUNSELING; PATIENT EDUCATION; QUESTIONNAIRE; VITAMIN INTAKE;

ADMINISTRATION, ORAL; ATTITUDE TO HEALTH; BONE DENSITY; CALCIUM; CROSS-SECTIONAL STUDIES; DIRECTIVE COUNSELING; FEMALE; GLUCOCORTICOIDS; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; OSTEOPOROSIS; QUESTIONNAIRES; VITAMIN D;

EID: 26844433031     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21446     Document Type: Article

References (35)

1. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002; 46:328-46.
2. Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 1994;96:115-23.
3. Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosterioids. Ann Rheum Dis 1986;45:852-7.
4. Hooyman JR, Melton LJ 3rd, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis: a population-based study. Arthritis Rheum 1984;27:1353-61.
5. Michel BA, Bloch DA, Fries JF. Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991;18:804-8.
6. Michel BA, Bloch DA, Wolfe F, Fries JF. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 1993;20:1666-9.
7. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995; 54:49-52.
8. Gudbjornsson B, Juliusson UI, Gudjonsson FV. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann Rheum Dis 2002;61:32-6.
9. Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 1990;150:2545-8.
10. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352-64.
11. Peat ID, Healy S, Reid DM, Ralston SH. Steroid induced osteoporosis: an opportunity for prevention? Ann Rheum Dis 1995;54:66-8.
12. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 1996;313:344-6.
13. Aagaard EM, Lin P, Modin GW, Lane NE. Prevention of glucocorticoid- induced osteoporosis: provider practice at an urban county hospital. Am J Med 1999;107:456-60.
14. Yood RA, Harrold LR, Fish L, Cernieux J, Emani S, Conboy E, et al. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch Intern Med 2001; 161:1322-7.
15. Buckley LM, Marquez M, Feezor R, Ruffin DM, Benson LL. Prevention of corticosteroid-induced osteoporosis: results of a patient survey. Arthritis Rheum 1999;42:1736-9.
16. Osiri M, Saag KG, Ford AM, Moreland LW. Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis. J Clin Rheum 2000;6:117-22.
17. Smith MD, Cheah SP, Taylor K, Ahern MJ. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital. J Rheumatol 2001;28:566-70.
18. Solomon DH, Katz JN, Jacobs JP, la Tourette AM, Coblyn J. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 2002; 46:3136-42.
19. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 2001;44:1496-503.
20. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria for rheumatoid arthritis. JAMA 1949;40:659-62.
21. Dillman DA. Mail and internet surveys: the tailored design method. 2nd ed. New York: Wiley; 2000.
22. Blalock SJ, Currey SS, DeVellis RF, Anderson JJ, Gold DT, Dooley MA. Using a short food frequency questionnaire to estimate dietary calcium consumption: a tool for patient education. Arthritis Care Res 1998;11:479-84.
23. Blalock SJ, Norton LL, Patel RA, Cabral K, Thomas CL. Development and assessment of a short instrument for assessing dietary intakes of calcium and vitamin D. J Am Pharm Assoc (Wash) 2003;43:685-93.
24. Block G, Thompson FE, Hartman AM, Larkin FA, Guire KE. Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 1992;92:686-93.
25. Block G, Wakimoto P, Block T. A revision of the Block Dietary Questionnaire and database, based on NHANES III data. Berkeley: University of California at Berkeley; June 25 1998.
26. Block G, Hartman AM, Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology 1990;1:58-64.
27. Cummings SR, Block G, McHenry K, Baron RB. Evaluation of two food frequency methods of measuring dietary calcium intake. Am J Epidemiol 1987;126:796-802.
28. Horan ML, Kim KK, Gendler P, Froman RD, Patel MD. Development and evaluation of the Osteoporosis Self-Efficacy Scale. Res Nurs Health 1998;21:395-403.
29. Kim KK, Horan ML, Gendler P, Patel MK. Development and evaluation of the Osteoporosis Health Belief Scale. Res Nurs Health 1991;14:155-63.
30. Blalock SJ, DeVellis RF, Giorgino KB, DeVellis BM, Gold DT, Dooley MA, et al. Osteoporosis prevention in premenopausal women: using a stage model approach to examine the predictors of behavior. Health Pyschol 1996;15:84-93.
31. Blalock SJ, Currey SS, DeVellis RF, DeVellis BM, Giorgino KB, Anderson JJ, et al. Effects of educational materials concerning osteoporosis on women's knowledge, beliefs, and behavior. Am J Health Promot 2000;14:161-9.
32. Kravitz RL, Hays RD, Sherbourne CD, DiMatteo MR, Rogers WH, Ordway L, et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med 1993;153:1869-78.
33. Flocke SA, Stange KC. Direct observation and patient recall of health behavior advice. Prev Med 2004;38:343-9.
34. Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, et al. Stages of change and decisional balance for 12 problem behaviors. Health Pyschol 1994;13:39-46.
35. Solomon DH, Katz JN, la Tourette AM, Coblyn JS. Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial. Arthritis Rheum 2004;51:383-7.